Evidence Library

Filter by drug, type, year, and open access.

Drug

Type

Year ≥

Sort

Open access

Active filters:Drug: paliperidone-palmitate ×Clear filters

Showing 1–2 of 2 results

Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia: A Randomized Clinical Trial — JAMA Psychiatry (2015)• Drug: paliperidone-palmitateDOI PMID
Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: a randomized, double-blind, placebo-controlled study — Schizophrenia Research (2010)• Drug: paliperidone-palmitateDOI PMID

PsychMed Evidence Library — Guidelines, Trials, Meta-Analyses